BioCentury
ARTICLE | Company News

Dr. Reddy's, ICICI Venture deal

April 4, 2005 7:00 AM UTC

ICICI Venture has agreed to pay $56 million to fund development and commercialization of undisclosed generic compounds in exchange for royalties. ICICI will fund development, registration and legal co...